Kidney transplant from controlled donors following circulatory death: Results from the GEODAS-3 multicentre study
Nefrologia (Engl Ed). 2019 Mar-Apr;39(2):151-159.
doi: 10.1016/j.nefro.2018.07.013.
Epub 2018 Nov 27.
[Article in
English,
Spanish]
Authors
José M Portolés
1
, María José Pérez-Sáez
2
, Paula López-Sánchez
3
, Omar Lafuente-Covarrubias
3
, Javier Juega
4
, Domingo Hernández
5
, Jordi Espí
6
, María Dolores Navarro
7
, María Auxiliadora Mazuecos
8
, María Luisa Rodríguez-Ferrero
9
, Naroa Maruri-Kareaga
10
, Francesc Moreso
11
, Edoardo Melilli
12
, Erika de Souza
13
, Juan Carlos Ruiz
14
, Francisco Llamas
15
, Alex Gutiérrez-Dalmau
16
, Luis Guirado
17
, Paloma Martín-Moreno
18
, Isabel Pérez Flores
19
, Antón Fernández-García
20
, Carlos Jiménez
21
, Eva Gavela
22
, Ana Ramos
23
, Julio Pascual
24
; en representación del grupo GEODAS
Affiliations
- 1 Hospital Universitario Puerta de Hierro, Madrid, España. Electronic address: [email protected].
- 2 Hospital del Mar, Barcelona, España.
- 3 Hospital Universitario Puerta de Hierro, Madrid, España.
- 4 Hospital Universitario Germán Trías y Pujol, Barcelona, España.
- 5 Hospital Universitario Carlos Haya, Málaga, España.
- 6 Hospital Universitario La Fe, Valencia, España.
- 7 Hospital Universitario Reina Sofía, Córdoba, España.
- 8 Hospital Universitario Puerta del Mar, Cádiz, España.
- 9 Hospital General Universitario Gregorio Marañón,, Madrid, España.
- 10 Hospital Universitario Cruces, Bilbao, España.
- 11 Hospital Universitario de Vall d́Hebron, Barcelona, España.
- 12 Hospital Universitario Bellvitge, Barcelona, España.
- 13 Hospital Universitario Clinic de Barcelona, Barcelona, España.
- 14 Hospital Universitario Marqués de Valdecilla, Santander, España.
- 15 Hospital Universitario de Albacete, Albacete, España.
- 16 Hospital Universitario Miguel Servet , Zaragoza, España.
- 17 Fundación Puigvert, Barcelona, España.
- 18 Clínica Universidad de Navarra, Pamplona, España.
- 19 Hospital Universitario Clínico San Carlos, Madrid, España.
- 20 Complexo Hospitalario Universitario A Coruña, La Coruña, España.
- 21 Hospital Universitario de la Paz, Madrid, España.
- 22 Hospital Universitario Dr. Peset, Valencia, España.
- 23 Fundación Jiménez Díaz, Madrid, España.
- 24 Hospital del Mar, Barcelona, España. Electronic address: [email protected].
Abstract
Introduction:
Many European countries have transplant programmes with controlled donors after cardiac death (cDCD). Twenty-two centres are part of GEODAS group. We analysed clinical results from a nephrological perspective.
Methods:
Observational, retrospective and multicentre study with systematic inclusion of all kidney transplant recipients from cDCD, following local protocols regarding extraction and immunosuppression.
Results:
A total of 335 cDCD donors (mean age 57.2 years) whose deaths were mainly due to cardiovascular events were included. Finally, 566 recipients (mean age 56.5 years; 91.9% first kidney transplant) were analysed with a median of follow-up of 1.9 years. Induction therapy was almost universal (thymoglobulin 67.4%; simulect 32.8%) with maintenance with prednisone-MMF-tacrolimus (91.3%) or combinations with mTOR (6.5%). Mean cold ischaemia time (CIT) was 12.3h. Approximately 3.4% (n=19) of recipients experienced primary non-function, essentially associated with CIT (only CIT ≥ 14 h was associated with primary non-function). Delayed graft function (DGF) was 48.8%. DGF risk factors were CIT ≥ 14 h OR 1.6, previous haemodialysis (vs. peritoneal dialysis) OR 2.1 and donor age OR 1.01 (per year). Twenty-one patients (3.7%) died with a functioning graft, with a recipient and death-censored graft survival at 2-years of 95% and 95.1%, respectively. The estimated glomerular filtration rate at one year of follow-up was 60.9 ml/min.
Conclusions:
CIT is a modifiable factor for improving the incidence of primary non-function in kidney transplant arising from cDCD. cDCD kidney transplant recipients have higher delayed graft function rate, but the same patient and graft survival compared to brain-dead donation in historical references. These results are convincing enough to continue fostering this type of donation.
Keywords:
Clinical outcomes; Delayed graft function; Donación tras parada circulatoria controlada; Donation with controlled donors after circulatory death; Función retrasada del injerto; Kidney transplant; Resultados clínicos; Trasplante renal.
Copyright © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.
Publication types
-
Multicenter Study
-
Observational Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Cause of Death
-
Child
-
Child, Preschool
-
Cold Ischemia / adverse effects
-
Cold Ischemia / statistics & numerical data
-
Delayed Graft Function / epidemiology
-
Delayed Graft Function / etiology
-
Female
-
Glomerular Filtration Rate
-
Graft Survival
-
Heart Arrest* / mortality
-
Humans
-
Kaplan-Meier Estimate
-
Kidney Transplantation* / mortality
-
Kidney Transplantation* / statistics & numerical data
-
Male
-
Middle Aged
-
Organ Preservation / methods
-
Retrospective Studies
-
Spain
-
Time Factors
-
Tissue Donors* / statistics & numerical data
-
Transplant Recipients / statistics & numerical data
-
Treatment Outcome
-
Young Adult